Increasing PK activity in PRs genetically via PKM2-to-PKM1 isoform switch or selective pharmacologic activation of PKM2 using a small molecule leads to PR neuroprotection following experimental retinal detachment [4,22]. Here, PKM is linked to retinal detachment.